BMS drug Eliquis (apixaban) is an oral Factor Xa inhibitor, targeted at stroke prevention in adult patients with NVAF and the prevention and treatment of VTE disorders. Eliquis has been jointly developed and is commercialized by Pfizer and Bristol-Myers Squibb Company (BMS). MNG Tracker report title “Eliquis Drug Sales & Forecast” provides historical as well as estimated Eliquis sales in Global, United States and Rest of the World market. This is single page report which also covered key factors for the growth/decline of the Eliquis sales in Global, United States and Rest of the World market.
MNG Tracker is a market research company which offer market research reports and database subscription service. Continuous tracking on latest changes in the industry and predict about the emerging needs, challenges and opportunities, is the essential needs for the growth of the business. MNG Tracker is exists for that. MNG Tracker is steadily monitored on the latest happening in the industries, companies and regulatory policies around the world. MNG Tracker is all about market, research and data. We know our clients; who they are, what they see and what they do. MNG Tracker team is fully dedicated to achieve their needs and expectation.
125/5D, Sector 5 Vrindavan Yojna,
Lucknow - 226002, India
Phone:+91 8527886312,
+ 91 7530849871
Email: info@mngtracker.com
FOLLOW USCOPYRIGHT © 2018 MNG Tracker. All Rights Reserved.